Navelbine 50mginjection 1Vial x 5ml(vinorelbine) (VINORELBINE TARTRATE)

Reference priceJPY ¥91,875.00Original source price: INR 52,500.00. Converted estimates are available by currency selection.

Brand	Navelbine
Manufacturer	PIERRE FABRE PHARM
Prescription required	Yes

Description

Navelbine 50mginjection 1Vial x 5ml(vinorelbine) (VINORELBINE TARTRATE) is a medicine catalog record in the MediPriceHub database. Active ingredient: VINORELBINE TARTRATE. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: PIERRE FABRE PHARM. Therapeutic category: Medicine Library > Oncology Medicines > Malignant pleural mesothelioma. Pack information: 50 5. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.

Benefits

Vinorelbine Injection is indicated: In combination with cisplatin for first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) As a single agent for the treatment of patients with metastatic NSCLC

How to Use

Use VINORELBINE TARTRATE under the supervision of a qualified healthcare professional. It should be prepared and administered only by trained healthcare professionals in a setting appropriate for injectable or infusion medicines. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.

Specification

Active ingredient: VINORELBINE TARTRATE. Pack size: 50 5. Pack unit: bottle. Manufacturer: PIERRE FABRE PHARM. Origin country: United States. Source category: Medicine Library > Oncology Medicines > Malignant pleural mesothelioma. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.

Side Effects

The available source record does not provide a clean, product-specific adverse-reaction list. Potential risks depend on the active ingredient, dose, route, treatment duration, and patient condition. Check the approved local prescribing information for the complete adverse-reaction profile, warnings, contraindications, and monitoring requirements. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, serious bleeding, or rapidly worsening symptoms.

この情報は参考情報です。医薬品を使用する前に医療専門家へご相談ください。